German pharmaceutical companies have criticized the US-EU agreement

The Association of German Research-Based Pharmaceutical Companies (VFA) has described the EU-US trade agreement as a “major step backward” for global healthcare and for Europe as a center of innovation.

 

“In…

Continue Reading